STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more

<iframe
  src="https://statesidedaily.com/embed/cluster/32c4f90c1b3ccf67620d6fb27fde3c877bcad81c"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more"></iframe>